PathXL Limited is a company specialising in software products for digital pathology.
The company’s products revolve around whole slide digital scans or virtual slides and provide unique tools for a wide range of applications addressing growing needs in the education, research and clinical markets.
PathXL was sold to the multinational health technology company, Royal Philips (NYSE: PHG, AEX: PHIA), in June 2016.
PathXL Limited is a company specialising in software products for digital pathology.